Medication-assisted treatment (mat) is widely considered the gold standard for the treatment of OPIOID use disorder

including by the American Society for Addiction Medicine (ASAM) and Substance Abuse and Mental Health Services Administration (SAMHSA). MAT using medications such as buprenorphine has been shown to reduce mortality from opioid use by more than half.

Buprenorphine (commonly known as Suboxone) is a partial agonist that partially fills opioid receptors which allows the medication to prevent withdrawals, but has a “ceiling effect” which prevents abuse.